Ocrelizumab-induced Psoriasis in A Patient with Relapsing-Remitting Multiple Sclerosis. EJMED [Internet]. 2023 May 2 [cited 2025 Oct. 11];5(3):1-2. Available from: https://www.ej-med.org/index.php/ejmed/article/view/1697